Update: As of April 13 2018 state approval is no longer required for medicinal cannabis products. Please see this article for an overview of federal regulations
To prescribe medicinal cannabis products in New South Wales, doctors must apply for federal approval from the Therapeutic Goods Administration (TGA), as well as gain state approval from the NSW health authority. State approval depends upon which schedule listing the medical cannabis products are classified as. Approval forms can be downloaded from the TGA and State Health websites using the links displayed in the table below, or the CannabisAccess medical cannabis portal may be used for online submissions. Submissions must be made on a per-patient basis and usually take between 1 – 6 days for approval.
|State||Schedule Listing||TGA Approval Process||State Approval Process|
|New South Wales||Schedule 4||SAS B||not required|
|New South Wales||Schedule 8||SAS B||NSW Health Approval|
Once approval is given from the TGA, the doctor will receive an approval certificate that must be provided to the medicinal cannabis product supplier before the product can be legally dispatched. Once approval is given from the NSW State Health Department, the pharmacist will receive an approval certificate, which is required to legally dispense the product to the patient.